Fig. 4.
BDCM exposure and CYP2E1-dependent modulation of hepatic glucose and fat metabolism. (A) Liver mRNA expression of glucose transporter (Glut-1, Glut-4), glycolytic enzyme (PFK), and gluconeogenic enzyme (PCK-1) in DIO, DIO + BDCM, and CYP2E1 KO + BDCM mice (n = 3). (B) Liver mRNA expression of lipid metabolism master regulator, PGC-1α, lipogenic gene SREBP-1c, and regulators of lipid metabolism, PPAR-α and PPAR-γ in DIO, DIO + BDCM, and CYP2E1 KO + BDCM mice (n = 3). *p < 0.05 is considered statistically significant.